Full-Time

Sales Development Representative

Medical Device-Remote within New York City, New Jersey, Philadelphia territory

Updated on 7/23/2026

Deadline 11/6/26
Varian

Varian

5,001-10,000 employees

Tech-enabled radiation oncology hardware and software

Compensation Overview

$68.2k - $93.7k/yr

+ Commission

Company Historically Provides H1B Sponsorship

Remote in USA

Remote

Remote in the United States; territory includes New York City, New Jersey, and Philadelphia.

Category
Sales & Account Management (1)

Get referred to Varian

Find people who can refer or advise you

Requirements
  • Ability to satisfy all customer vendor credentialing requirements, including immunizations, background screening, and site-specific access requirements.
  • Completion of all required company compliance, product, and clinical training programs.
  • This role is governed by Fleet Safety Policy. To be eligible for employment, applicants must hold a valid driver’s license in the state they reside and may not have any prior DUI/DWI convictions or pending DUI/DWI charges or other serious moving violations (unless such a restriction is prohibited by state/local law).
  • Bachelor’s Degree or equivalent professional experience.
  • Demonstrated success in medical device sales, healthcare sales, or other complex consultative sales environments.
  • Experience selling capital equipment, disposable technologies, or clinically sophisticated products preferred.
  • Proven ability to develop new business while growing existing customer relationships.
  • Strong business acumen and territory planning skills.
  • Excellent communication, presentation, negotiation, and relationship-building abilities.
  • Ability to learn complex clinical technologies and effectively communicate their value to physicians and healthcare executives.
  • Proficiency with CRM systems, Microsoft Office, and other business productivity tools.
  • Prior Interventional Oncology experience is valuable, but we are equally interested in high-performing sales professionals who have consistently demonstrated the ability to build business, launch new products, and succeed in complex healthcare environments.
Responsibilities
  • Build new physician, hospital, and health system relationships throughout your territory.
  • Develop new accounts while expanding utilization within existing customers.
  • Execute strategic territory business plans designed to exceed sales objectives.
  • Drive adoption of innovative technologies through clinical expertise, education, and consultative selling.
  • Partner with physicians and healthcare teams to improve procedural outcomes and patient care.
  • Lead product launches and commercial initiatives across your territory.
  • Collaborate closely with Clinical Specialists, Marketing, Medical Affairs, Sales Operations, and Sales Leadership.
  • Analyze market opportunities, competitive activity, and customer needs to identify new growth opportunities.
  • Deliver exceptional customer experiences before, during, and after every sale.
  • Represent Siemens Healthineers with the highest standards of integrity, professionalism, and customer commitment.
  • Travel approximately 40–50% within the assigned territory.
Desired Qualifications
  • Love winning new business.
  • Enjoy introducing new technologies to the market.
  • Take ownership and accountability for results.
  • Move with urgency and purpose.
  • Build trust quickly with physicians and healthcare executives.
  • Thrive in changing, fast-paced environments.
  • Are naturally curious and continuously learning.
  • Remain positive and resilient through challenges.
  • Are highly organized and disciplined.
  • Care deeply about patients, customers, and teammates.
  • Take pride in representing a world-class organization.
  • Bachelor’s Degree or equivalent professional experience.
  • Demonstrated success in medical device sales, healthcare sales, or other complex consultative sales environments.
  • Experience selling capital equipment, disposable technologies, or clinically sophisticated products preferred.
  • Proven ability to develop new business while growing existing customer relationships.
  • Strong business acumen and territory planning skills.
  • Excellent communication, presentation, negotiation, and relationship-building abilities.
  • Ability to learn complex clinical technologies and effectively communicate their value to physicians and healthcare executives.
  • Proficiency with CRM systems, Microsoft Office, and other business productivity tools.
  • Prior Interventional Oncology experience is valuable, but we are equally interested in high-performing sales professionals who have consistently demonstrated the ability to build business, launch new products, and succeed in complex healthcare environments.

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Telix collaboration integrates PET imaging with Ethos adaptive radiotherapy.
  • Halcyon installations expand into Saudi Arabia and Sri Lanka markets.
  • TrueBeam FDA clearance treats osteoarthritis for 33 million US patients.

What critics are saying

  • EU MDR Class III reclassification halts OaaS rollouts, cuts 25% renewals.
  • Eleksia cyclotrons capture 40% of Varian's $2B proton backlog by Q4 2026.
  • ViewRay APAC linacs undercut Halcyon with 30% faster treatments by mid-2026.

What makes Varian unique

  • Varian's ProBeam system powers New York Proton Center with $115M deal.
  • HyperSight imaging enhances Ethos, Halcyon, Edge, TrueBeam precision.
  • IntelliBlate microwave ablation creates controlled spherical zones for oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.

PR Newswire
Jul 29th, 2024
Varian Announces Future-Focused, Integrated Microwave Ablation Ecosystem With Intelliblate

PALO ALTO, Calif., July 29, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IntelliBlate microwave ablation system, intended for ablation of soft tissue. Designed to provide clinicians with greater predictability, precision, and control during their procedures, IntelliBlate serves as the cornerstone of a future-focused, integrated ecosystem for microwave ablation.IntelliBlate produces large, controlled spherical ablation zones for predictable treatment delivery. With the option to utilize a single or dual probes – each with linked or independent controls – IntelliBlate delivers the versatility to meet the unique clinical needs of each patient. Precision and control are amplified by the Ximitry probe, which enables innovative features such as Laser Disk Alignment and intuitive LED indicators.The compact, versatile design and intuitive interface of IntelliBlate delivers a portable and flexible system that reduces barriers for this important treatment method. Modular elements provide the flexibility for clinicians to expand their treatment capabilities to meet changing clinical demands, all while keeping control over operational efficiency throughout the ablation procedure."IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation," says Dr

PR Newswire
May 2nd, 2024
Together With Siemens Healthineers, Varian Showcases Commitment To Embracing Innovation And Enhancing Outcomes At Estro 2024

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting, which will take place from May 3 to 7 in Glasgow, Scotland.With over 24 million new cancer cases expected by 2030, accessible, high-quality cancer treatment is crucial to improving patient outcomes1. Radiotherapy is an integral part of therapeutic treatments for approximately 50% of the patients diagnosed with cancer, yet many countries have inadequate availability of radiotherapy treatment2. Varian is working in collaboration with healthcare providers to change that statistic by creating innovative and integrated solutions to help bring treatment options to those communities who need it most."As part of Siemens Healthineers, Varian is in a unique position to develop cutting-edge products and solutions that bridge the care gap globally," remarked Arthur Kaindl, Head of Varian. "By combining the expertise of the leading imaging and radiotherapy companies, we have the ability to achieve much more than any individual cancer care company by driving connection throughout the entire care continuum."At the ESTRO meeting, Varian will present a range of solutions that will enhance the care continuum, including:HyperSight imaging solution is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems.is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems